Nothing Special   »   [go: up one dir, main page]

FI970983A - Molekyylien siirto solujen sytoplasmaan - Google Patents

Molekyylien siirto solujen sytoplasmaan Download PDF

Info

Publication number
FI970983A
FI970983A FI970983A FI970983A FI970983A FI 970983 A FI970983 A FI 970983A FI 970983 A FI970983 A FI 970983A FI 970983 A FI970983 A FI 970983A FI 970983 A FI970983 A FI 970983A
Authority
FI
Finland
Prior art keywords
cells
molecules
cytoplasm
transfer
photodynamic treatment
Prior art date
Application number
FI970983A
Other languages
English (en)
Swedish (sv)
Other versions
FI121328B (fi
FI970983A0 (fi
Inventor
Kristian Berg
Kirsten Sandvik
Johan Moan
Original Assignee
Photocure As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photocure As filed Critical Photocure As
Publication of FI970983A publication Critical patent/FI970983A/fi
Publication of FI970983A0 publication Critical patent/FI970983A0/fi
Application granted granted Critical
Publication of FI121328B publication Critical patent/FI121328B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Catalysts (AREA)
FI970983A 1994-09-08 1997-03-07 Molekyylien siirto solujen sytosoliin FI121328B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
NO943327A NO180167C (no) 1994-09-08 1994-09-08 Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
NO943327 1994-09-08
NO9500149 1995-09-04
PCT/NO1995/000149 WO1996007432A1 (en) 1994-09-08 1995-09-04 Transfer of molecules into the cytosol of cells

Publications (3)

Publication Number Publication Date
FI970983A true FI970983A (fi) 1997-03-07
FI970983A0 FI970983A0 (fi) 1997-03-07
FI121328B FI121328B (fi) 2010-10-15

Family

ID=19897382

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970983A FI121328B (fi) 1994-09-08 1997-03-07 Molekyylien siirto solujen sytosoliin

Country Status (20)

Country Link
US (3) US5876989A (fi)
EP (1) EP0783323B1 (fi)
JP (1) JP4148328B2 (fi)
KR (2) KR100529967B1 (fi)
CN (1) CN1222309C (fi)
AT (1) ATE209507T1 (fi)
AU (1) AU700797B2 (fi)
BR (1) BRPI9508825B8 (fi)
CA (1) CA2199290C (fi)
CZ (1) CZ65897A3 (fi)
DE (1) DE69524238T2 (fi)
ES (1) ES2163527T3 (fi)
FI (1) FI121328B (fi)
HK (1) HK1004110A1 (fi)
HU (1) HU222984B1 (fi)
MX (1) MX9701676A (fi)
NO (1) NO180167C (fi)
NZ (2) NZ293008A (fi)
PT (1) PT783323E (fi)
WO (1) WO1996007432A1 (fi)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO180167C (no) 1994-09-08 1997-02-26 Photocure As Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
US6176842B1 (en) * 1995-03-08 2001-01-23 Ekos Corporation Ultrasound assembly for use with light activated drugs
US6210356B1 (en) * 1998-08-05 2001-04-03 Ekos Corporation Ultrasound assembly for use with a catheter
ATE409005T1 (de) * 1997-03-19 2008-10-15 Lucid Inc Zellchirurgie unter benutzung konfokaler mikroskopie
US6676626B1 (en) 1998-05-01 2004-01-13 Ekos Corporation Ultrasound assembly with increased efficacy
US6582392B1 (en) 1998-05-01 2003-06-24 Ekos Corporation Ultrasound assembly for use with a catheter
JP2002500201A (ja) * 1998-01-05 2002-01-08 ユニバーシティ オブ ワシントン 膜破壊剤を使用する増強された輸送
US6399769B1 (en) * 1998-01-20 2002-06-04 Kimberly-Clark Worldwide, Inc. Method of making sulfanatophenyl substituted porphines
GB9905911D0 (en) 1999-03-15 1999-05-05 Photocure As Method
WO2001019953A1 (fr) * 1999-09-09 2001-03-22 Center For Advanced Science And Technology Incubation, Ltd. Procede de perçage de membrane et appareil a cet effet
US7807780B2 (en) * 2000-07-21 2010-10-05 Revance Therapeutics, Inc. Multi-component biological transport systems
US20040220100A1 (en) * 2000-07-21 2004-11-04 Essentia Biosystems, Inc. Multi-component biological transport systems
PL213560B1 (pl) * 2000-11-29 2013-03-29 Pci Biotech As Sposób wprowadzania czasteczki do cytozolu komórki in vitro lub ex vivo, zastosowanie medyczne oraz kompozycja
KR101180548B1 (ko) * 2000-11-29 2012-09-06 피씨아이 바이오테크 에이에스 사이토졸 내로의 바이러스 매개된 분자 전달을 위한 광화학적 내부이행
US20020098472A1 (en) * 2000-11-30 2002-07-25 Erlach Julian Van Method for inserting a microdevice or a nanodevice into a body fluid stream
US20020137901A1 (en) * 2001-01-22 2002-09-26 Cavanaugh Philip Gerard Synthesis, and photodynamic therapy-mediated anti-cancer, and other uses of chlorin e6-transferrin
US20030031655A1 (en) * 2001-02-08 2003-02-13 Sequitur, Inc. Methods of light activated release of ligands from endosomes
JP4081436B2 (ja) * 2001-06-20 2008-04-23 大日本住友製薬株式会社 核酸導入を促進させる方法
GB0121023D0 (en) 2001-08-30 2001-10-24 Norwegian Radium Hospital Res Compound
EP1647232B1 (en) 2001-12-03 2011-08-17 Ekos Corporation Catheter with multiple ultrasound radiating members
US7141044B2 (en) * 2001-12-11 2006-11-28 Ekos Corporation Alternate site gene therapy
US20060009409A1 (en) 2002-02-01 2006-01-12 Woolf Tod M Double-stranded oligonucleotides
WO2003064621A2 (en) * 2002-02-01 2003-08-07 Ambion, Inc. HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES
DK2128248T4 (en) 2002-02-01 2017-03-13 Life Technologies Corp Oligonucleotide compositions with increased efficiency
US8226629B1 (en) 2002-04-01 2012-07-24 Ekos Corporation Ultrasonic catheter power control
US20040248094A1 (en) * 2002-06-12 2004-12-09 Ford Lance P. Methods and compositions relating to labeled RNA molecules that reduce gene expression
GB0215534D0 (en) * 2002-07-04 2002-08-14 Ecole Polytech Selective photochemotherapy using oligonucleotide targeting agents
US20040029275A1 (en) * 2002-08-10 2004-02-12 David Brown Methods and compositions for reducing target gene expression using cocktails of siRNAs or constructs expressing siRNAs
US6921371B2 (en) * 2002-10-14 2005-07-26 Ekos Corporation Ultrasound radiating members for catheter
EP1587908A4 (en) * 2003-01-09 2008-02-20 Invitrogen Corp RELEASE AND ACTIVATION OF COMPLEX CELLS OF POLYPEPTIDES AND NUCLEIC ACIDS
US7332477B2 (en) * 2003-07-10 2008-02-19 Nitto Denko Corporation Photocleavable DNA transfer agent
JP4586022B2 (ja) * 2003-09-29 2010-11-24 日東電工株式会社 インビボポリヌクレオチド送達用生分解性ポリアセタール
US20080318319A1 (en) * 2003-12-19 2008-12-25 Yoshiko Minakuchi Novel Method of Nucleic Acid Transfer
CA2558676C (en) * 2004-03-03 2019-04-16 Essentia Biosystems, Inc. Compositions and methods for topical diagnostic and therapeutic transport
ES2554821T3 (es) * 2004-03-03 2015-12-23 Revance Therapeutics, Inc. Aplicación tópica y liberación transdérmica de toxinas botulínicas
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
GB0415263D0 (en) * 2004-07-07 2004-08-11 Norwegian Radium Hospital Res Method
US20060094781A1 (en) * 2004-11-04 2006-05-04 Syneron Medical Ltd. Method of treating extracellular matrix
FR2877943B1 (fr) * 2004-11-16 2008-09-05 Univ De Coimbra Nouveaux derives de porphyrine, notamment chlorines et/ou bacteriochlorine, et leurs applications en therapie photodynamique
US20090247464A1 (en) 2005-03-03 2009-10-01 Revance Therapeutics, Inc. Compositions and Methods for Topical Application and Transdermal Delivery of an Oligopeptide
RU2007136616A (ru) 2005-03-03 2009-04-10 Риванс Терапьютикс, Инк. (Us) Композиция и способ для местного применения и чрескожного введения ботулинового токсина
US7674452B2 (en) * 2005-03-16 2010-03-09 Nitto Denko Corporation Polymer coating of cells
BRPI0501037B8 (pt) 2005-03-18 2021-07-27 Fund De Amparo A Pesquisa Do Estado De Sao Paulo uso de crotamina e composição
KR101423272B1 (ko) * 2005-11-17 2014-07-30 레반스 테라퓨틱스, 아이엔씨. 감소된 비-독소 단백질을 갖는 보툴리눔 독소의 국소 적용및 경피 전달을 위한 조성물 및 방법
WO2007109584A1 (en) * 2006-03-16 2007-09-27 University Of Washington Temperature-and ph-responsive polymer compositions
GB0613753D0 (en) * 2006-07-11 2006-08-23 Norwegian Radium Hospital Res Method
AU2007333225B2 (en) * 2006-12-08 2014-06-12 Massachusetts Institute Of Technology Delivery of nanoparticles and/or agents to cells
CN102988995A (zh) * 2006-12-29 2013-03-27 雷文斯治疗公司 用源自hiv-tat的多肽片段稳定的肉毒杆菌毒素的组合物及其局部施用和透皮递送的方法
US20100093639A1 (en) * 2006-12-29 2010-04-15 Revance Therapeutics, Inc. Transport Molecules Using Reverse Sequence HIV-TAT Polypeptides
US10182833B2 (en) 2007-01-08 2019-01-22 Ekos Corporation Power parameters for ultrasonic catheter
US7981688B2 (en) 2007-03-08 2011-07-19 University Of Washington Stimuli-responsive magnetic nanoparticles and related methods
EP2494932B1 (en) 2007-06-22 2020-05-20 Ekos Corporation Apparatus for treatment of intracranial hemorrhages
US20090187137A1 (en) * 2007-12-14 2009-07-23 Kim Volz Ultrasound pulse shaping
GB0811955D0 (en) 2008-06-30 2008-07-30 Pci Biotech As Method
US8426214B2 (en) * 2009-06-12 2013-04-23 University Of Washington System and method for magnetically concentrating and detecting biomarkers
GB0914286D0 (en) 2009-08-14 2009-09-30 Pci Biotech As Method
GB0914287D0 (en) 2009-08-14 2009-09-30 Pci Biotech As Compositions
US9080933B2 (en) 2009-11-09 2015-07-14 University Of Washington Through Its Center For Commercialization Stimuli-responsive polymer diagnostic assay comprising magnetic nanoparticles and capture conjugates
US20110117668A1 (en) * 2009-11-09 2011-05-19 University Of Washington Through Its Center For Commercialization Self-powered smart diagnostic devices
GB201208548D0 (en) * 2012-05-15 2012-06-27 Pci Biotech As Compound and method
US20160040128A1 (en) 2013-03-15 2016-02-11 Pci Biotech As Method
GB2517707B (en) 2013-08-28 2020-09-02 Pci Biotech As A device for light-induced rupture of endocytic vesicles to effect the delivery of an antigen
WO2015028574A1 (en) 2013-08-28 2015-03-05 Pci Biotech As Compound and method for vaccination and immunisation
WO2015154832A1 (en) 2014-04-11 2015-10-15 Pci Biotech As Method of treating melanoma
EP3185901B1 (en) 2014-08-28 2023-10-04 PCI Biotech AS Compound and method
GB201503776D0 (en) 2015-03-05 2015-04-22 Pci Biotech As Compound and method
WO2016201136A1 (en) 2015-06-10 2016-12-15 Ekos Corporation Ultrasound catheter
KR20190068573A (ko) 2016-10-14 2019-06-18 피씨아이 바이오테크 에이에스 젬시타빈의 tpcs-2a 유도된 광화학 내재화로의 담관암의 치료
GB201718631D0 (en) 2017-11-10 2017-12-27 Pci Biotech As Method
GB201801169D0 (en) * 2018-01-24 2018-03-07 Pci Biotech As Method
WO2020017962A1 (en) 2018-07-16 2020-01-23 Dcprime B.V. A combination product for use in tumor vaccination.
AU2020264083A1 (en) 2019-04-25 2021-12-02 Mendus B.V. Methods of tumor vaccination
CN110711249B (zh) * 2019-09-19 2020-10-27 北京化工大学 一种溶酶体膜包覆纳米颗粒的制备方法
CA3172447A1 (en) 2020-03-27 2021-09-30 Erik Hans MANTING In vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy
WO2021191870A1 (en) 2020-03-27 2021-09-30 Dcprime B.V. Ex vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy
CN114163508B (zh) * 2020-09-11 2024-07-16 王月志 能破坏细胞的氨基酸序列及相关核苷酸序列和相关的应用
CA3196677A1 (en) 2020-11-05 2022-05-12 Erik Hans MANTING Use of tumor-independent antigens in immunotherapies
GB202101726D0 (en) 2021-02-08 2021-03-24 Pci Biotech As Method
EP4304633A1 (en) 2021-03-12 2024-01-17 Mendus B.V. Methods of vaccination and use of cd47 blockade
GB202115451D0 (en) 2021-10-27 2021-12-08 Pci Biotech As Method
WO2024068795A1 (en) 2022-09-27 2024-04-04 Pci Biotech As Method for releasing viral vectors
GB202301312D0 (en) 2023-01-30 2023-03-15 Pci Biotech As Method and product
GB202404168D0 (en) 2024-03-22 2024-05-08 Pci Biotech As Method

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU563827B2 (en) 1982-07-01 1987-07-23 Millipore Corp. Filtration apparatus
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US4704255A (en) 1983-07-15 1987-11-03 Pandex Laboratories, Inc. Assay cartridge
US5066274A (en) * 1985-04-30 1991-11-19 Nippon Petrochemicals Company, Ltd. Tetrapyrrole therapeutic agents
US5076950A (en) 1985-12-20 1991-12-31 Syntex (U.S.A.) Inc. Magnetic composition for particle separation
US4895706A (en) 1986-10-28 1990-01-23 Costar Corporation Multi-well filter strip and composite assemblies
US5095030A (en) * 1987-01-20 1992-03-10 University Of British Columbia Wavelength-specific cytotoxic agents
NO891491D0 (no) * 1987-08-12 1989-04-11 Peter Nemeth Prosedyre for befrielse av celleblandinger og vev for uoenskede populasjoner.
HU204856B (en) 1987-08-12 1992-02-28 Orszagos Mueszaki Fejlesztesi Process for releasing cell mixtures and tissues from undesired populations and for producing monoclonal antibody - hematoporphyrin conjugates
GB8721108D0 (en) * 1987-09-08 1987-10-14 Salford University Of Liposomes
US5284647A (en) * 1988-03-18 1994-02-08 Schering Aktiengesellschaft Mesotetraphenylporphyrin complex compounds, process for their production and pharmaceutical agents containing them
US5256532A (en) 1988-05-02 1993-10-26 Zynaxis Technologies, Inc. Methods, reagents and test kits for determination of subpopulations of biological entities
US4925736A (en) * 1988-07-06 1990-05-15 Long Island Jewish Medical Center Topical hematoporphyrin
GB8905001D0 (en) 1989-03-04 1989-04-19 Univ Leicester Screening for natural products of microbial metabolism
US4935498A (en) * 1989-03-06 1990-06-19 Board Of Regents, The University Of Texas System Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles
US5567687A (en) * 1989-03-06 1996-10-22 University Of Texas Texaphyrins and uses thereof
US5328470A (en) * 1989-03-31 1994-07-12 The Regents Of The University Of Michigan Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
US5059619A (en) * 1989-06-14 1991-10-22 Quadra Logic Technologies, Inc. Stable freeze-dried polyhematoporphyrin ether/ester
DE3919873A1 (de) 1989-06-19 1990-12-20 Behringwerke Ag Magnetische protein-konjugate, verfahren zu ihrer herstellung und ihre verwendung
GB8916859D0 (en) 1989-07-24 1989-09-06 Dynal As Hapten linking
GB8929297D0 (en) 1989-12-29 1990-02-28 Dynal As Method of separation
US5200084A (en) 1990-09-26 1993-04-06 Immunicon Corporation Apparatus and methods for magnetic separation
US5491068A (en) 1991-02-14 1996-02-13 Vicam, L.P. Assay method for detecting the presence of bacteria
US5179120A (en) * 1991-06-28 1993-01-12 Cytopharm, Inc. Porphycene compounds for photodynamic therapy
PL165249B1 (pl) * 1991-10-29 1994-11-30 Wojskowa Akad Tech Sposób otrzymywania soli kompleksowych hematoporfiryny i jej pochodnych PL PL PL PL PL PL PL
US5376546A (en) * 1991-11-04 1994-12-27 Xoma Corporation Analogs of ribosome-inactivating proteins
US5258453A (en) * 1992-01-21 1993-11-02 University Of Utah Drug delivery system for the simultaneous delivery of drugs activatable by enzymes and light
JP2635216B2 (ja) * 1992-03-16 1997-07-30 アイシス・ファーマシューティカルス・インコーポレーテッド プロテインキナーゼｃのオリゴヌクレオチド調節
CA2131090A1 (en) 1992-03-20 1993-09-21 Peter Leonard Grant Method and apparatus for the analysis of biological material
AU4115693A (en) * 1992-04-24 1993-11-29 Sri International In vivo homologous sequence targeting in eukaryotic cells
WO1994007138A1 (en) 1992-09-14 1994-03-31 Fodstad Oystein Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
EP0672133B1 (en) * 1992-11-03 2004-06-16 Gene Shears Pty Limited TNF-alpha RIBOZYMES AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-alpha RIBOZYMES
FR2700010B1 (fr) 1992-12-24 1995-03-17 Rocher Yves Biolog Vegetale Méthode et dispositif pour tester la réactivité de cellules à l'égard de produits.
US5374531A (en) 1993-03-22 1994-12-20 Zynaxis, Inc. Immunoassay for determination of cells
US5861310A (en) * 1993-11-03 1999-01-19 Dana-Farber Cancer Institute Tumor cells modified to express B7-2 with increased immunogenicity and uses therefor
US5491084A (en) * 1993-09-10 1996-02-13 The Trustees Of Columbia University In The City Of New York Uses of green-fluorescent protein
US6015897A (en) * 1993-12-07 2000-01-18 Neorx Corporation Biotinamido-n-methylglycyl-seryl-o-succinamido-benzyl dota
US5514340A (en) 1994-01-24 1996-05-07 Magnetix Biotechnology, Inc. Device for separating magnetically labelled cells
NO180658C (no) 1994-03-10 1997-05-21 Oeystein Fodstad Fremgangsmåte og anordning for deteksjon av spesifikke målceller i spesialiserte eller blandede cellepopulasjoner og opplösninger som inneholder blandede cellepopulasjoner
NO180167C (no) 1994-09-08 1997-02-26 Photocure As Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
US5872007A (en) * 1995-02-17 1999-02-16 Hybridon, Inc. CAPL-specific oligonucleotides and methods of inhibiting metastatic cancer

Also Published As

Publication number Publication date
CZ65897A3 (en) 1997-10-15
ES2163527T3 (es) 2002-02-01
KR970705415A (ko) 1997-10-09
BRPI9508825B1 (pt) 2020-12-22
EP0783323A1 (en) 1997-07-16
US20030134813A1 (en) 2003-07-17
DE69524238D1 (de) 2002-01-10
CN1222309C (zh) 2005-10-12
CA2199290C (en) 2010-10-26
CN1164829A (zh) 1997-11-12
WO1996007432A1 (en) 1996-03-14
NZ509519A (en) 2004-10-29
CA2199290A1 (en) 1996-03-14
HUT77469A (hu) 1998-05-28
HU222984B1 (hu) 2004-01-28
JPH10508295A (ja) 1998-08-18
US20020155099A1 (en) 2002-10-24
ATE209507T1 (de) 2001-12-15
AU3534795A (en) 1996-03-27
US6680301B2 (en) 2004-01-20
JP4148328B2 (ja) 2008-09-10
FI121328B (fi) 2010-10-15
DE69524238T2 (de) 2002-07-18
NZ293008A (en) 2001-04-27
KR20040004402A (ko) 2004-01-13
MX9701676A (es) 1998-04-30
PT783323E (pt) 2002-03-28
NO180167C (no) 1997-02-26
EP0783323B1 (en) 2001-11-28
AU700797B2 (en) 1999-01-14
NO180167B (no) 1996-11-18
BRPI9508825B8 (pt) 2021-07-06
NO943327D0 (no) 1994-09-08
BR9508825A (pt) 1998-01-06
KR100395615B1 (ko) 2003-12-31
NO943327L (no) 1996-03-11
FI970983A0 (fi) 1997-03-07
KR100529967B1 (ko) 2005-11-22
US5876989A (en) 1999-03-02
HK1004110A1 (en) 1998-11-20

Similar Documents

Publication Publication Date Title
FI970983A (fi) Molekyylien siirto solujen sytoplasmaan
DK1681355T3 (da) Sekvensspecifik DNA-rekombination i eukaryote celler
DE69830663D1 (de) Nicht-primaten lentivirale vektoren und verpackungssysteme
BR0012325A (pt) Métodos e composições para prevenção da formação de rna anormal durante a transcrição de uma sequência de plasmìdeo
NO970049D0 (no) Nukleinsyre holdt i preparat, dets fremstilling og anvendelse
BR0210839A (pt) Sistema de recombinação, método para remover uma sequência de dna do dna cromossÈmico de uma célula ou organismo eucarióticos, organismo, cultura de célula, órgão, tecido, parte ou material de propagação transgênico, e, uso de um organismo ou de uma cultura de célula, órgão, tecido, parte ou material de propagação transgênico
MXPA03002413A (es) Moleculas tipo b7 y uso de las mismas.
EP0827410A4 (en) METHOD FOR INTRODUCING AND EXPRESSING GENES IN ANIMAL CELLS
SE9704076D0 (sv) Method for permeabilisation of cell structures and use thereof
DK0923592T3 (da) Fremgangsmåder til rensning af nukleinsyrer
EP0883344A4 (en) THERAPEUTIC MOLECULES OBTAINED BY TRANS-SPLITTING
FI973467A (fi) DNA-molekyylejä, valmistus ja käyttö geeniterapiassa
BR0009471A (pt) Composições e processos para modificação de transcrição de gene
EP1686181A3 (en) Methods for enhanced virus-mediated DNA transfer using molecules with virus-and cell-binding domains
WO2001029175A3 (en) Antisense modulation of fra-1 expression
AU2672099A (en) Compositions and methods for wound healing
NZ307444A (en) Polyphenol oxidase genes from lettuce and banana
WO2003012031A3 (en) Antisense modulation of stearoyl-coa desaturase expression
WO2000061729A3 (en) Regulation of the expression of transcriptional repressor genes using nucleic acid molecules
GEP19991780B (en) Use of Pyrrolidine Derivatives for Treating Alcoholism
DE69733948D1 (de) In vivo herstellung von replicativen molekülen
WO2001012798A3 (en) Male sterile plants
EP1094115A4 (en) NEGATIVE STRENGTH RNA VIRUS VECTOR
ATE382090T1 (de) Kommerzielle herstellung von laccase in pflanzen
ATE295884T1 (de) Dna-expressionskonstrukt zur behandlung von infektionen mit leishmaniose

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 121328

Country of ref document: FI

MA Patent expired